{"id":3202,"date":"2017-12-18T16:35:07","date_gmt":"2017-12-18T15:35:07","guid":{"rendered":"https:\/\/aliber.org\/web\/2017\/12\/18\/estudio-sobre-las-erns-retos-en-europa-y-espana\/"},"modified":"2017-12-18T16:35:07","modified_gmt":"2017-12-18T15:35:07","slug":"estudio-sobre-las-erns-retos-en-europa-y-espana","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2017\/12\/18\/estudio-sobre-las-erns-retos-en-europa-y-espana\/","title":{"rendered":"Estudio sobre las ERNs: retos en Europa y Espa\u00f1a"},"content":{"rendered":"<p>&#013;\n<\/p>\n<p>Nuria Mar\u00eda Garrido Cuenca, Profesora Titular de Derecho Adminsitrativo de la Universidad de Castilla La Mancha y Patrona de la Fundaci\u00f3n Espa\u00f1ola de Mastocitosis, ha publicado el estudio: &#8216;Las Redes Europeas de Referencia (ERNs) de Enfermedades Raras: un hito en la historia de la coordinaci\u00f3n transfronteriza en materia de salud. Los retos log\u00edsticos, de telemedicina y jur\u00eddicos&#8217;.<\/p>\n<p>&#013;<\/p>\n<p>En este estudio, se analiza el origen y evoluci\u00f3n de la pol\u00edtica de Redes Europeas de Referencia y se plantean los retos a nivel europeo y nacional tras la puesta en marcha de las primeras 24 ERNs en marzo de 2017, como el inicio de una nueva era de la cooperaci\u00f3n voluntaria transfronteriza en materia de salud.<\/p>\n<p>&#013;<\/p>\n<p style=\"text-align: right\">\u00daltima actualizaci\u00f3n: 18\/12\/2017.<\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nSource: FEDER<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#013; Nuria Mar\u00eda Garrido Cuenca, Profesora Titular de Derecho Adminsitrativo de la Universidad de Castilla La Mancha y Patrona de la Fundaci\u00f3n Espa\u00f1ola de Mastocitosis, ha publicado el estudio: &#8216;Las<a href=\"https:\/\/aliber.org\/web\/2017\/12\/18\/estudio-sobre-las-erns-retos-en-europa-y-espana\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"false","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[7],"tags":[24],"class_list":["post-3202","post","type-post","status-publish","format-standard","hentry","category-socios","tag-enfermedades-raras"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/3202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=3202"}],"version-history":[{"count":0,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/3202\/revisions"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=3202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=3202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=3202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}